ReviewTargeted oncology2016

Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer.

Hartmut Kristeleit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.